Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00711451 · ClinicalTrials.gov registry record · NA

Manual and Expressed Placental Removal at Cesarean Delivery and Its Effects on Various Cardiac Indices

A NA study, sponsored by Corewell Health East.

Terminated
Registry status
NA
Development phase
19
Enrollment target

NCT00711451: Clinical Trial NA study, sponsored by Corewell Health East.

NCT00711451 is a NA study that was terminated before completion, run by Corewell Health East. The registered enrollment target is 19 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00711451, a NA study, was terminated before completion, sponsored by Corewell Health East.

TERMINATED
Registry status
NA
Development phase
19 participants
Enrollment target

Study Summary

The purpose of this study is to evaluate whether manual removal of the placenta during a cesarean delivery results in higher changes in the resistance of blood flow throughout the body, also called systemic vascular resistance (SVR)

Interventions

  • BEHAVIORAL Manual removal
  • PROCEDURE Expressed removal

Trial Details

FieldValue
Enrollment Target 19 participants
Start Date 2008-07
Est. Completion 2012-01
Phase NA
Corewell Health East

106 total trials

Why NCT00711451 stopped before completion

NCT00711451 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 19 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 2 interventions - of which Manual removal is the first listed.

NCT00711451 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00711451 about?

NCT00711451 is a clinical study titled "Manual and Expressed Placental Removal at Cesarean Delivery and Its Effects on Various Cardiac Indices". The purpose of this study is to evaluate whether manual removal of the placenta during a cesarean delivery results in higher changes in the resistance of blood flow throughout the body, also called systemic vascular resistance (SVR)

What is the current status of trial NCT00711451?

This trial is currently terminated. It is a NA study. The enrollment target is 19 participants. The study started on 2008-07. Estimated completion is 2012-01.

What interventions are being tested in trial NCT00711451?

The interventions under investigation include: Manual removal (BEHAVIORAL), Expressed removal (PROCEDURE).

Who is sponsoring clinical trial NCT00711451?

This trial is sponsored by Corewell Health East, which has 106 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00711451's enrollment target sits among peer trials

19 1861st of 2000 higher than 138 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03207464 · 19 participants · Phase 1

    Molecular Imaging of NET Using [C-11]MRB-PET in MS

  • NCT04318717 · 19 participants · Phase 2

    Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma

  • NCT05103904 · 19 participants · Phase 2

    Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant

  • NCT05607407 · 19 participants · Phase 2

    Methimazole in Patients With Progressive Glioblastoma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00711451, the US trial registry maintained by the National Library of Medicine. NCT00711451 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.